Position
Chief Financial Officer
Company
Alkeus Pharmaceuticals
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Alkeus Pharmaceuticals, Inc. has announced the appointment of David Arkowitz, M.B.A., as their new Chief Financial Officer. David brings more than 30 years of finance, operations, business development and commercial leadership experience in the life sciences and biotech industries.
Quick answer
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024). Alkeus Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Financial Officer at Alkeus Pharmaceuticals?
- Alkeus Pharmaceuticals named David Arkowitz Chief Financial Officer, announced October 31, 2024.
- What did Alkeus Pharmaceuticals announce on October 31, 2024?
- Alkeus Pharmaceuticals, Inc. has announced the appointment of David Arkowitz, M.B.A., as their new Chief Financial Officer. David brings more than 30 years of finance, operations, business development and commercial leadership experience in the life sciences and biotech industries.
- What does Alkeus Pharmaceuticals do?
- Alkeus Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
- Where is Alkeus Pharmaceuticals based?
- Alkeus Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Tarsus Pharmaceuticals (November 5, 2024), Arecor Therapeutics PLC (November 18, 2024), NRx Pharmaceuticals (November 18, 2024) and BerGenBio ASA (November 20, 2024) also announced leadership changes within 45 days of Alkeus Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc. (September 23, 2024)
Who to call at Alkeus Pharmaceuticals, and when
A new leader at Alkeus Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alkeus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alkeus Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alkeus Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alkeus Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alkeus Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.